Charlotta Ryk

1.7k total citations
20 papers, 734 citations indexed

About

Charlotta Ryk is a scholar working on Molecular Biology, Surgery and Physiology. According to data from OpenAlex, Charlotta Ryk has authored 20 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Surgery and 7 papers in Physiology. Recurrent topics in Charlotta Ryk's work include Bladder and Urothelial Cancer Treatments (8 papers), Nitric Oxide and Endothelin Effects (4 papers) and Glutathione Transferases and Polymorphisms (4 papers). Charlotta Ryk is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Nitric Oxide and Endothelin Effects (4 papers) and Glutathione Transferases and Polymorphisms (4 papers). Charlotta Ryk collaborates with scholars based in Sweden, Germany and Belarus. Charlotta Ryk's co-authors include Rajiv Kumar, Petra J. de Verdier, Gunnar Steineck, Kari Hemminki, Peter Wiklund, Sai‐Mei Hou, P. Sivaramakrishna Rachakonda, Barbara Heidenreich, Md. Ismail Hosen and Dirk Schadendorf and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Urology and International Journal of Cancer.

In The Last Decade

Charlotta Ryk

20 papers receiving 725 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotta Ryk Sweden 14 407 215 206 140 109 20 734
Shilpa Lingala United States 10 264 0.6× 199 0.9× 154 0.7× 170 1.2× 114 1.0× 19 920
Toshiyuki Kitoh Japan 16 246 0.6× 84 0.4× 82 0.4× 249 1.8× 51 0.5× 41 809
Hideaki Yahata Japan 15 268 0.7× 47 0.2× 144 0.7× 190 1.4× 80 0.7× 70 1.1k
Giannoula Soufla Greece 18 245 0.6× 70 0.3× 85 0.4× 125 0.9× 84 0.8× 33 646
Matthew F. Buas United States 17 507 1.2× 117 0.5× 337 1.6× 99 0.7× 205 1.9× 28 999
Jonathan S.T. Sham Hong Kong 17 341 0.8× 61 0.3× 363 1.8× 555 4.0× 163 1.5× 32 1.1k
Cornelia Bachmann Germany 13 99 0.2× 173 0.8× 170 0.8× 102 0.7× 33 0.3× 33 545
Joseph Tung‐Chieh Chang Taiwan 14 235 0.6× 88 0.4× 413 2.0× 377 2.7× 132 1.2× 18 1.0k
C Billerey France 12 365 0.9× 28 0.1× 526 2.6× 108 0.8× 63 0.6× 42 854
Marion Couch United States 6 229 0.6× 50 0.2× 213 1.0× 312 2.2× 96 0.9× 6 705

Countries citing papers authored by Charlotta Ryk

Since Specialization
Citations

This map shows the geographic impact of Charlotta Ryk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotta Ryk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotta Ryk more than expected).

Fields of papers citing papers by Charlotta Ryk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotta Ryk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotta Ryk. The network helps show where Charlotta Ryk may publish in the future.

Co-authorship network of co-authors of Charlotta Ryk

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotta Ryk. A scholar is included among the top collaborators of Charlotta Ryk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotta Ryk. Charlotta Ryk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hedman, Linnéa, Maria Rosaria Galanti, Charlotta Ryk, Hans Gilljam, & Louise Adermark. (2021). Electronic cigarette use and smoking cessation in cohort studies and randomized trials: A systematic review and meta-analysis. Tobacco Prevention & Cessation. 7(October). 1–16. 35 indexed citations
2.
Adermark, Louise, Maria Rosaria Galanti, Charlotta Ryk, Hans Gilljam, & Linnéa Hedman. (2021). Prospective association between use of electronic cigarettes and use of conventional cigarettes: a systematic review and meta-analysis. ERJ Open Research. 7(3). 976–2020. 30 indexed citations
3.
4.
Ryk, Charlotta, et al.. (2015). Polymorphisms In The Nitric-Oxide Synthase 2 Gene And Prostate Cancer Pathogenesis. Redox Biology. 5. 419–419. 6 indexed citations
5.
Ryk, Charlotta, et al.. (2015). Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes. Redox Biology. 6. 272–277. 16 indexed citations
6.
Verdier, Petra J. de, et al.. (2015). FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib‐mediated cytotoxicity. Pharmacology Research & Perspectives. 3(5). e00171–e00171. 18 indexed citations
7.
Hosen, Md. Ismail, P. Sivaramakrishna Rachakonda, Barbara Heidenreich, et al.. (2015). Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer. International Journal of Cancer. 137(7). 1621–1629. 76 indexed citations
8.
Ryk, Charlotta, Sai‐Mei Hou, Göran Pershagen, et al.. (2014). The (CCTTT)n microsatellite polymorphism in the NOS2 gene may influence lung cancer risk and long-term survival, especially in non-smokers. Tumor Biology. 35(5). 4425–34. 2 indexed citations
9.
10.
Rachakonda, P. Sivaramakrishna, Md. Ismail Hosen, Petra J. de Verdier, et al.. (2013). TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proceedings of the National Academy of Sciences. 110(43). 17426–17431. 272 indexed citations
11.
Ryk, Charlotta, Peter Wiklund, Tommy Nyberg, & Petra J. de Verdier. (2011). Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer. Nitric Oxide. 25(3). 338–343. 24 indexed citations
12.
Ryk, Charlotta, Peter Wiklund, Tommy Nyberg, & Petra J. de Verdier. (2011). Ser608Leu polymorphisms in the nitric oxide synthase-2 gene may influence urinary bladder cancer pathogenesis. Scandinavian Journal of Urology and Nephrology. 45(5). 319–325. 6 indexed citations
13.
Ryk, Charlotta, Gunnar Steineck, Peter Wiklund, Tommy Nyberg, & Petra J. de Verdier. (2010). The (CCTTT)n Microsatellite Polymorphism in the Nitric Oxide Synthase 2 Gene May Influence Bladder Cancer Pathogenesis. The Journal of Urology. 184(5). 2150–2157. 10 indexed citations
14.
Ryk, Charlotta, Michael N. Routledge, James M. Allan, et al.. (2008). Influence of DNA repair gene polymorphisms on the initial repair of MMS‐induced DNA damage in human lymphocytes as measured by the alkaline comet assay. Environmental and Molecular Mutagenesis. 49(9). 669–675. 6 indexed citations
15.
Littorin, Margareta, Sai‐Mei Hou, Karin Bröberg, et al.. (2007). Influence of polymorphic metabolic enzymes on biotransformation and effects of diphenylmethane diisocyanate. International Archives of Occupational and Environmental Health. 81(4). 429–441. 9 indexed citations
16.
Ryk, Charlotta, Rajiv Kumar, Ranjit K. Thirumaran, & Sai‐Mei Hou. (2006). Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. Lung Cancer. 54(3). 285–292. 88 indexed citations
17.
Sanyal, Somali, Charlotta Ryk, Petra J. de Verdier, et al.. (2006). Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms. Scandinavian Journal of Urology and Nephrology. 41(3). 182–190. 14 indexed citations
18.
Ryk, Charlotta, Rajiv Kumar, Somali Sanyal, et al.. (2005). Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours. Cancer Letters. 241(1). 142–149. 38 indexed citations
19.
Ryk, Charlotta, Petra Berggren, Rajiv Kumar, et al.. (2004). Influence of GSTM1, GSTT1, GSTP1 and NAT2 genotypes on the p53 mutational spectrum in bladder tumours. International Journal of Cancer. 113(5). 761–768. 19 indexed citations
20.
Hou, Sai‐Mei, Charlotta Ryk, Annamaria Kannio, et al.. (2003). Influence of common XPD and XRCC1 variant alleles on p53 mutations in lung tumors. Environmental and Molecular Mutagenesis. 41(1). 37–42. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shilpa Lingala Breakdown of academic impact, for papers by Toshiyuki Kitoh Breakdown of academic impact, for papers by Hideaki Yahata Breakdown of academic impact, for papers by Giannoula Soufla Breakdown of academic impact, for papers by Matthew F. Buas Breakdown of academic impact, for papers by Jonathan S.T. Sham Breakdown of academic impact, for papers by Cornelia Bachmann Breakdown of academic impact, for papers by Joseph Tung‐Chieh Chang Breakdown of academic impact, for papers by C Billerey Breakdown of academic impact, for papers by Marion Couch
Rankless by CCL
2026